Company intelligence / Profile preview

RedC Biotech

Bnei Zion, Center District / Tel Aviv District, Israelredcbiotech.com ↗

Ownership: Private
Employees: ~6
Development stage: Other

Overview

RedC Biotech has developed a proprietary process to generate universal donor-free red blood cells from human stem cells at industrial scale. The company remains pre-clinical but has demonstrated small-scale production and aims to address global shortages in safe RBC supply with pathogen-free products compatible with nearly all patients. No clinical trial results have been reported yet.

Therapeutic areas: HematologyOther
Modalities: Cell therapyBiologicRecombinant protein
Industry: Biotech

Partnerships

Technion – Israel Institute of Technology (exclusive partnership/licensing)

Beyond the preview

Go deeper on RedC Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RedC Biotech.

Explore the full profile